Modified Nucleosides
5-Methyl-5,6-dihydrouridine
Quick view. Uridine derivative with reduction across base positions 5 and 6 and a methyl substituent at base position 5; the base C5 configuration is unspecified. CAS 23067-10-9. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
5-Methyl-5,6-dihydrouridine is classified as modified nucleosides (Formula C10H16N2O6; molecular weight 260.24 g/mol).
5-Methyl-5,6-dihydrouridine is associated with uridine-containing substrates for U-position incorporation in RNA or modified RNA studies.
For 5-Methyl-5,6-dihydrouridine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Useful catalog search terms
- 23067-10-9
Physicochemical data
| PubChem CID | 21772594 |
|---|---|
| Nucleoside scaffold | 5,6-Dihydrouridine |
| Substitution pattern | Base-5-methyl |
| Stereochemical scope | Ribose stereochemistry defined; base C5 configuration unspecified |
| IUPAC name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione |
| InChIKey | BTFXIEGOSDSOGN-KWCDMSRLSA-N |
| InChI | InChI=1S/C10H16N2O6/c1-4-2-12(10(17)11-8(4)16)9-7(15)6(14)5(3-13)18-9/h4-7,9,13-15H,2-3H2,1H3,(H,11,16,17)/t4?,5-,6-,7-,9-/m1/s1 |
| SMILES | CC1CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)NC1=O |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-0719(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Modified Nucleosides · CAS: 96392-15-3
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
Frequently asked questions
Can the package size for 5-Methyl-5,6-dihydrouridine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0402 and CAS 23067-10-9, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.